In a bid to support businesses during the most recent wave of increasing coronavirus cases, the Government has announced that from mid-January, it will be reintroducing the Statutory Sick Pay Rebate Scheme (SSP). This previous scheme ended on 30th September 2021.

For small and medium enterprises, employers can reclaim SSP for up to two weeks where an employee been off sick due to a coronavirus related absence. Currently employers will pay £96.35 per week in SSP.

This scheme only impacts small and medium sized businesses who have fewer than 250 employees.

The purpose of reintroducing the scheme is to help relieve some of the pressure felt by businesses during high levels of sickness absence that has been caused by the omicron variant.

The government website indicates that further guidance is to be published shortly.

Read about emergency changes to the rules on self certifying sickness absence.

5th January 2022

FREE first advice

Have you ever wanted to just ask an expert employment law solicitor if they can help you, without worrying about what it may cost to contact them?

Get in touch

We’d like to talk to you to see what we can do to help, so please either call us anytime for free on 08000 614 631, email us or use the form below.

      Together we can work out what your next steps might be...in confidence, at no cost and with no obligation.

      SIGN UP TO RECEIVE UP TO THE MINUTE EMPLOYMENT LAW AND HR NEWS STRAIGHT TO YOUR INBOX

      * indicates required
      McCabe and Co Solicitors will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:
      You can change your mind at any time by clicking the unsubscribe link in the footer of any email you receive from us, or by contacting us at philip@mccabeandco.com. We will treat your information with respect. For more information about our privacy practices please visit our website. By clicking below, you agree that we may process your information in accordance with these terms.
      We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.